Leboulleux, Sophie

Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients

Baudin, E., Cao, C. D., Cailleux, A. F., Leboulleux, S., Travagli, J. P., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 278

Prognostic parameters of metastatic adrenocortical carcinoma

Assié, G., Antoni, G., Tissier, F., Caillou, B., Abiven, G., Gicquel, C., Leboulleux, S., Travagli, J.-P., Dromain, C., Bertagna, X., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 236

Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study

Hermsen, I. G., Fassnacht, M., Terzolo, M., Houterman, S., den Hartigh, J., Leboulleux, S., Daffara, F., Berruti, A., Chadarevian, R., Schlumberger, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 173

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

Terzolo, M., Baudin, A. E., Ardito, A., Kroiss, M., Leboulleux, S., Daffara, F., Perotti, P., Feelders, R. A., deVries, J. H., Zaggia, B., et al. (2013) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 134

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

Leboulleux, S., Deandreis, D., Al Ghuzlan, A., Aupérin, A., Goéré, D., Dromain, C., Elias, D., Caillou, B., Travagli, J. P., De Baere, T., et al. (2010) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 133

Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.

Vezzosi, D., Walter, T., Laplanche, A., Raoul, J. L., Dromain, C., Ruszniewski, P., d'Herbomez, M., Guigay, J., Mitry, E., Cadiot, G., et al. (2011) · The International Journal of Biological Markers

Neuroendocrine Tumor Research AdvancesNeuroblastoma Research and Treatments

Cited by 43